Canada: The Court Of Appeal Limits The Disclosure Of Documents Prior To The Authorization Of A Class Action Instituted Under The Securities Act

On January 29th, in the course of interlocutory proceedings in connection with a class action filed against Amaya for making false or misleading statements on the secondary market, contrary to Quebec's Securities Act (the "Act")1, the Court of Appeal ruled on a request for disclosure of documents prior to the authorization (certification) of the class action2.

The Court of Appeal granted Amaya's motion for leave to appeal and upheld the Superior Court's decision, but solely as regards the order therein to disclose insurance policies, and it dismissed the applicant's requests for disclosure of all other documents.

Recap of the Superior Court's decision3

In February 2017, the Superior Court granted the applicants' motion seeking disclosure of certain documents before the hearing on authorization of the class action, including Amaya's "Disclosure, Confidentiality and Trading Policy" and its directors' and officers' liability insurance policies.

In its reasons for judgment, the Superior Court set out a three-step test for the disclosure of evidence at the pre-authorization stage. The purpose of the test was to create a framework for pre-authorization disclosure in order to avoid "fishing expeditions" and limit the scope of disclosure to what was truly necessary. After applying the test, the Court found that the applicants' motion respected not only the requirements of cooperation and openness under Article 20 of the Code of Civil Procedure (the "CCP") but also the considerations of practicality and fairness that are essential for the proper, efficient and cost-effective administration of justice.

This decision of the Superior Court changed the well-established rule in the case law regarding disclosure of evidence prior to the authorization of a class action. Hitherto, there had been no disclosure whatsoever at that stage of the proceedings. It was therefore up to those seeking authorization to conduct an investigation in order to gather sufficient facts and information to meet the authorization criteria.

Following this decision, the applicants in a class action were provided with additional procedural means at their disposal to bolster their file with information and documents that they could now obtain from the respondent through a disclosure order.

The Court of Appeal's decision: a return to the established rule

On August 29th, 2017 Amaya moved for leave to appeal the Superior Court's judgment ordering disclosure of documents prior to the authorization of the class action instituted against it. On January 29th, 2018, the Court of Appeal rendered its decision, in which it essentially disposed of three issues:

  1. the application for leave to appeal;
  2. the request for disclosure of documents prior to authorization of the class action, and
  3. the request for disclosure of Amaya's directors' and officers' liability insurance policies.

First of all, regarding the motion for leave to appeal the Superior Court judgment, it is interesting to note that the judgment is covered by the second paragraph of Article 31 CCP as it "determines part of the dispute or causes irremediable injury to a party". The Court of Appeal pointed out that it is not a decision on case management measures relating to the conduct of the proceeding, as contemplated by Article 32 CCP. In light of the principles laid down in Theratechnologies4] and the potential for irreparable harm to Amaya as a result of the Superior Court's decision, the Court of Appeal granted leave to appeal.

The Court then went on to determine whether it was appropriate to compel disclosure of documents prior to the authorization of a class action. In this instance, the appeal dealt with the disclosure of documents prior to the authorization contemplated by section 225.4 of the Act:

Following a detailed analysis of the provisions of the CCP and the case law, including the principles laid down in Theratechnologies, the Court of Appeal concluded that section 225.4 of the Act does not open the door to the disclosure of documents prior to the authorization of the class action. The purpose of the section, the Court found, is to protect issuers and non-plaintiff shareholders from frivolous lawsuits, rather than to allow applicants to bolster their file before the class action has even been authorized.

Some of the Court's comments are particularly interesting in this regard:

  1. The screening mechanism in section 225.4 is indeed designed, above all things, to protect public issuers against frivolous lawsuits brought by investors who have no meaningful evidence to show that they have been the victims of misconduct in the secondary market. It also serves to protect long-term shareholders of the issuer who, not party to the unmeritorious action, would bear the cost of any settlement paid to opportunistic plaintiffs. The screening mechanism thus contributes to protect the public confidence in the capital markets by ensuring that investors will not be held hostage to frivolous litigation. Finally, section 225.4 of the Act helps courts avoid costs and wasted time of frivolous or unmeritorious litigation. In that sense, it shares some of the policy foundation of rules that allow actions to be dismissed summarily as improper proceedings.

    ...

  1. None of the provisions cited, alone or grouped with the others, justifies allowing discovery in a manner that would amount to a change in the policy underlying section 225.4 of the Act. Importantly, it is not "unfair" to require a plaintiff-shareholder to show, according to the terms of the screening mechanism, that his or her proposed action is not a strike suit given the policy behind that rule to protect issuers, innocent shareholders, the markets and the courts. On the other hand, it would potentially be unfair to the issuer and to innocent shareholders, as well as to the justice system, to subject the parties to a "mini-trial" that might result if discovery was allowed. When section 225.4, paragraph 3, refers to the requirement that the putative plaintiff show "a reasonable possibility that it [i.e. the proposed action in the annexed projected statement of claim] will be resolved in favour of the plaintiff", the legislature refers to a reasonable possibility of that outcome at a trial down the road, one at which, where appropriate, discovery can be sought. At this stage, however, the evidentiary bar is lower than at trial – just some credible evidence to support the view that the suit is not destined to fail.

    [Emphasis added]

Finally, notwithstanding the foregoing, the Court of Appeal upheld the Superior Court's decision regarding the requested disclosure of Amaya's directors' and officers' liability insurance policies, , , partly in light of the wording of Article 20 CCP, but primarily because of Article 2501 of the Civil Code of Québec:

According to the Court of Appeal, Article 2501 CCQ allows a third party to sue either an insured or its insurer, or both. It would therefore be illogical to allow a suit by a third party against an insured, but deny it access to the latter's insurance policy, as that document is relevant to the debate. The Court also took the view that section 225.4 of the Act does not apply with respect to Amaya's insurance policies, in light of the principles set forth in Article 2501 CCQ.

This recent decision of the Court of Appeal restores the balance between the parties in the context of a motion to institute a class action in a securities-related matter, specifically one pursuant to section 225.4 of the Act. The principles set out in this decision provide useful guidance regarding the protective regime section 225.4 creates for the benefit of issuers and non-plaintiff shareholders. Finally, it should be noted that this decision recognizes the distinction between the motion for authorization of a class action and the jurisprudential test established in Theratechnologies, thereby affording additional protection to reporting issuers.

Footnotes

1 Securities Act, CQLR c. V-1.1

2 Amaya inc. v. Derome, 2018 QCCA 120.

3 Derome v. Amaya inc., 2017 QCCS 44. For more details on the Superior Court's decision, click here.

4 Theratechnologies inc. v. 121851 Canada inc., 2013 QCCA 1256.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Pierre Y. Lefebvre
Jessica Syms
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions